Beijing Centergate Technologies Holding Co 000931.SZ · CNY
Real Estate · Shenzhen · 🇨🇳 China
3.83
+0.52%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Beijing Centergate Technologies Holding Co
Its shares trade on Shenzhen under the ticker 000931.SZ. It has been listed since 12 July 1999. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.44bn and net income of CN¥47.9m. At that date it held total assets of CN¥4.00bn and shareholders' equity of CN¥1.64bn.
Beijing Centergate Technologies (Holding) Co., Ltd. engages in the development, management and investment of real estate. The company is headquartered in Beijing, Beijing. The firm mainly operates through Biomedicine Segment, Personal Care segment, Real Estate and Construction segment and Other segment. Biomedicine Segment is mainly engaged in the development, manufacture and sale of topical preparations, tablets, injections, Active Pharmaceutical Ingredients (APIs), capsules, oral solutions, granules, narcotic drugs and second class psychoactive drugs. Personal Care segment is mainly involved in the sale of oral cleaning products. Real Estate and Construction segment mainly includes the development and sale of real estates, as well as the manufacture and sale of concrete and cement products. Other segment is mainly involved in property management, catering, accommodation, centralized elderly services and investment business, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Real Estate
- Industry
- Real Estate Management & Development
- Listed since
- 12 Jul 1999
- Employees
- 2,374
- Website
- centek.com.cn ↗
Leadership
Pay as last reported
- Mr. Zhongmin XuChairman of the Board, since 2007CN¥810,540
- Mr. Zhanjun HouPresident, Director, since 2007CN¥650,000
- Mr. Xuewu SongChief Financial Officer, Vice President
- Mr. Zhiyu HuangVice President, Company SecretaryCN¥193,012
- Mr. Dehui CheVice President
- Ms. Xiujun FanVice President
- Mr. Bin LiVice President
- Ms. Xihong WangVice President
- Ms. Ping ChenDirector
- Ms. Xiuhong HuangDirector
- Mr. Ye ZhangDirector
- Mr. Xiaochun ZouDirector, since 2006
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company employs 2,374 full-time staff members across its diverse business operations.
- The Biomedicine Segment develops topical preparations, tablets, and injections for the market.
- The Real Estate and Construction segment manufactures concrete and cement products.
Weaknesses
- The Personal Care segment is limited to the sale of oral cleaning products.
- The Other segment includes property management and catering which may dilute focus.
- The company operates in Beijing, Beijing, which might limit geographic diversification.
Opportunities
- The Biomedicine Segment can expand its sale of Active Pharmaceutical Ingredients globally.
- The Real Estate segment can develop more real estates for sale.
- The Other segment can grow its centralized elderly services business.
Threats
- The Biomedicine Segment faces risks with narcotic drugs and psychoactive drugs.
- The Real Estate and Construction segment is sensitive to market fluctuations.
- The Personal Care segment relies on a narrow range of oral cleaning products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.